ISCO - International Stem Cell Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue7,1657,5517,017
Cost of Revenue1,9442,0561,921
Gross Profit5,2215,4955,096
Operating Expenses
Research Development2,8562,7075,386
Selling General and Administrative7,2167,3528,390
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-4,851-4,564-8,680
Income from Continuing Operations
Total Other Income/Expenses Net3,7781,940-3,796
Earnings Before Interest and Taxes-1,073-2,624-12,476
Interest Expense6112
Income Before Tax-1,079-2,635-12,478
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-1,079-2,635-12,478
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-1,079-2,635-12,478
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-1,079-2,635-12,478